BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15780615)

  • 1. Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists.
    Zhao H; Xin Z; Patel JR; Nelson LT; Liu B; Szczepankiewicz BG; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1825-8. PubMed ID: 15780615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of tetralin carboxamide growth hormone secretagogue receptor antagonists via scaffold manipulation.
    Zhao H; Xin Z; Liu G; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
    J Med Chem; 2004 Dec; 47(27):6655-7. PubMed ID: 15615511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists.
    Xin Z; Zhao H; Serby MD; Liu B; Schaefer VG; Falls DH; Kaszubska W; Colins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1201-4. PubMed ID: 15686942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists.
    Xin Z; Serby MD; Zhao H; Kosogof C; Szczepankiewicz BG; Liu M; Liu B; Hutchins CW; Sarris KA; Hoff ED; Falls HD; Lin CW; Ogiela CA; Collins CA; Brune ME; Bush EN; Droz BA; Fey TA; Knourek-Segel VE; Shapiro R; Jacobson PB; Beno DW; Turner TM; Sham HL; Liu G
    J Med Chem; 2006 Jul; 49(15):4459-69. PubMed ID: 16854051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.
    Liu B; Liu G; Xin Z; Serby MD; Zhao H; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5223-6. PubMed ID: 15380232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.
    Serby MD; Zhao H; Szczepankiewicz BG; Kosogof C; Xin Z; Liu B; Liu M; Nelson LT; Kaszubska W; Falls HD; Schaefer V; Bush EN; Shapiro R; Droz BA; Knourek-Segel VE; Fey TA; Brune ME; Beno DW; Turner TM; Collins CA; Jacobson PB; Sham HL; Liu G
    J Med Chem; 2006 Apr; 49(8):2568-78. PubMed ID: 16610800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: side chain exploration.
    Liu B; Liu M; Xin Z; Zhao H; Serby MD; Kosogof C; Nelson LT; Szczepankiewicz BG; Kaszubska W; Schaefer VG; Falls HD; Lin CW; Collins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1864-8. PubMed ID: 16442284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor.
    Witherington J; Abberley L; Bellenie BR; Boatman R; Collis K; Dean DK; Gaiba A; King NP; Shuker N; Steadman JG; Takle AK; Sanger G; Butler S; McKay F; Muir A; Winborn K; Ward RW; Heightman TD
    Bioorg Med Chem Lett; 2009 Feb; 19(3):684-7. PubMed ID: 19128969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists.
    Li FN; Kim NJ; Paek SM; Kwon DY; Min KH; Jeong YS; Kim SY; Park YH; Kim HD; Park HG; Suh YG
    Bioorg Med Chem; 2009 May; 17(10):3557-67. PubMed ID: 19398205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of the oxindole growth hormone secretagogues.
    Tokunaga T; Hume WE; Nagamine J; Kawamura T; Taiji M; Nagata R
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1789-92. PubMed ID: 15780607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisation.
    Witherington J; Abberley L; Briggs MA; Collis K; Dean DK; Gaiba A; King NP; Kraus H; Shuker N; Steadman JG; Takle AK; Sanger G; Wadsworth G; Butler S; McKay F; Muir A; Winborn K; Heightman TD
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2203-5. PubMed ID: 18316188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trp3, Arg5]-ghrelin(1-5) stimulates growth hormone secretion and food intake via growth hormone secretagogue (GHS) receptor.
    Ohinata K; Kobayashi K; Yoshikawa M
    Peptides; 2006 Jul; 27(7):1632-7. PubMed ID: 16530883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone secretagogue receptor antagonists as anti-obesity therapies? Still an open question.
    Zhao H; Liu G
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):509-15. PubMed ID: 16889233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R).
    Gauna C; van de Zande B; van Kerkwijk A; Themmen AP; van der Lely AJ; Delhanty PJ
    Mol Cell Endocrinol; 2007 Aug; 274(1-2):30-4. PubMed ID: 17601657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C.
    Falls HD; Dayton BD; Fry DG; Ogiela CA; Schaefer VG; Brodjian S; Reilly RM; Collins CA; Kaszubska W
    J Mol Endocrinol; 2006 Aug; 37(1):51-62. PubMed ID: 16901923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
    Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
    Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.
    Rudolph J; Esler WP; O'connor S; Coish PD; Wickens PL; Brands M; Bierer DE; Bloomquist BT; Bondar G; Chen L; Chuang CY; Claus TH; Fathi Z; Fu W; Khire UR; Kristie JA; Liu XG; Lowe DB; McClure AC; Michels M; Ortiz AA; Ramsden PD; Schoenleber RW; Shelekhin TE; Vakalopoulos A; Tang W; Wang L; Yi L; Gardell SJ; Livingston JN; Sweet LJ; Bullock WH
    J Med Chem; 2007 Oct; 50(21):5202-16. PubMed ID: 17887659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a).
    Carreira MC; Camiña JP; Díaz-Rodríguez E; Alvear-Perez R; Llorens-Cortes C; Casanueva FF
    J Endocrinol; 2006 Oct; 191(1):147-57. PubMed ID: 17065398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs.
    Zhang P; Bao L; Zuckett JF; Goldman EA; Jia ZJ; Arfsten A; Edwards S; Sinha U; Hutchaleelaha A; Park G; Lambing JL; Hollenbach SJ; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2004 Feb; 14(4):983-7. PubMed ID: 15013006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat.
    Sibilia V; Muccioli G; Deghenghi R; Pagani F; De Luca V; Rapetti D; Locatelli V; Netti C
    J Neuroendocrinol; 2006 Feb; 18(2):122-8. PubMed ID: 16420281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.